---
title: IDT Australia vs Stason Industrial Corporation
slug_a: idtaus-com
slug_b: stasonpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/idtaus-com/stasonpharma
---

# IDT Australia vs Stason Industrial Corporation

Side-by-side profile data from each company listing on this directory.

## IDT Australia

- Profile: [/companies/idtaus-com](/companies/idtaus-com)

IDT Australia — IDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support.

Services: 18. Modalities: 3. Indications: 3. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (18).

### Services

- Regulatory Affairs
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Radiopharmaceutical

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Oral Solid Dose (OSD)
- HPAPI
- DEA licensed

## Stason Industrial Corporation

- Profile: [/companies/stasonpharma](/companies/stasonpharma)

Stason Industrial Corporation — US-based CDMO offering contract packaging, analytical testing, and manufacturing services for clinical trial and commercial pharmaceutical production, with specialized high-containment capabilities for potent compounds.

Services: 10. Modalities: 1. Indications: 3. Locations: 2. Certifications: 1. The strongest documented coverage currently appears in services (10).

### Services

- Analytical Method Development & Validation
- ICH Stability Studies
- HPAPI Manufacturing (High-Potency)
- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)
- Lyophilized Vials
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI